What's in Pablo Rodríguez del Rio's pipeline?

Pablo Rodríguez del Rio has 2 drugs in our index: 2 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Pablo Rodríguez del Rio's portfolio?

Top competitors by shared drug class: Breath of Life International Pharma Ltd, Hospital Universitario de Canarias, Iowa City Veterans Affairs Medical Center, Pfizer, US Department of Veterans Affairs.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/pablo-rodr-guez-del-rio.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Pablo Rodríguez del Rio — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Pablo Rodríguez del Rio pipeline: 2 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

2 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
"Rush" regimen	"Rush" regimen	marketed	Amphetamine	Dopamine transporter	Central Nervous System
"Conventional" regimen	"Conventional" regimen	marketed	Norepinephrine-dopamine reuptake inhibitor		Psychiatry

Therapeutic area mix

Central Nervous System · 1
Psychiatry · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Breath of Life International Pharma Ltd · 1 shared drug class
Hospital Universitario de Canarias · 1 shared drug class
Iowa City Veterans Affairs Medical Center · 1 shared drug class
Pfizer · 1 shared drug class
US Department of Veterans Affairs · 1 shared drug class
VA Office of Research and Development · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Pablo Rodríguez del Rio:

Cite this brief

Drug Landscape (2026). Pablo Rodríguez del Rio — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/pablo-rodr-guez-del-rio. Accessed 2026-05-16.